Literature DB >> 11754531

ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.

K E Haneke1, R R Tice, B L Carson, B H Margolin, W S Stokes.   

Abstract

To evaluate the reliability of the murine local lymph node assay (LLNA), a test for allergic contact dermatitis activity, the inter- and intralaboratory consistency statistics (h and k, respectively) were calculated for validation studies testing multiple chemicals. The analysis indicated the absence of excessive variability in the dose calculated to induce a threefold or greater increase in the stimulation index (SI). To assess the appropriateness of using an SI of 3 as the decision criteria for identifying a sensitizing compound, LLNA results based on SI values of 2.0, 2.5, 3.0, 3.5, and 4.0 were compared with guinea pig or human results. The results supported the use of an SI of 3 as the decision criteria. Assay performance was determined by comparing LLNA results to results obtained for guinea pigs or humans. The accuracy of the LLNA was 89% when compared with results from the guinea pig maximization test (GPMT)/Buehler assay (BA). The performance of the LLNA and the GPMT/BA was similar when each was compared to human maximization test results plus substances included as human patch test allergens. The LLNA offered advantages over the GPMT in respect to both the time required to conduct the test and the assay cost.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754531     DOI: 10.1006/rtph.2001.1498

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  6 in total

1.  Safety assessment of allergic contact dermatitis hazards: an analysis supporting reduced animal use for the murine local lymph node assay.

Authors:  Joseph K Haseman; Judy Strickland; David Allen; Eleni Salicru; Michael Paris; Raymond R Tice; William S Stokes
Journal:  Regul Toxicol Pharmacol       Date:  2010-10-23       Impact factor: 3.271

2.  PreS/MD: Predictor of Sensitization Hazard for Chemical Substances Released From Medical Devices.

Authors:  Vinicius M Alves; Joyce V B Borba; Rodolpho C Braga; Daniel R Korn; Nicole Kleinstreuer; Kevin Causey; Alexander Tropsha; Diego Rua; Eugene N Muratov
Journal:  Toxicol Sci       Date:  2022-09-24       Impact factor: 4.109

3.  Reactivity measurement in estimation of benzoquinone and benzoquinone derivatives' allergenicity.

Authors:  Wilbes Mbiya; Itai Chipinda; Reuben H Simoyi; Paul D Siegel
Journal:  Toxicology       Date:  2015-12-02       Impact factor: 4.221

4.  A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests.

Authors:  Henrik Johansson; Malin Lindstedt; Ann-Sofie Albrekt; Carl A K Borrebaeck
Journal:  BMC Genomics       Date:  2011-08-08       Impact factor: 3.969

5.  Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency.

Authors:  Ann-Sofie Albrekt; Henrik Johansson; Anna Börje; Carl Borrebaeck; Malin Lindstedt
Journal:  BMC Pharmacol Toxicol       Date:  2014-02-11       Impact factor: 2.483

6.  Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.

Authors:  Andy Forreryd; Henrik Johansson; Ann-Sofie Albrekt; Carl A K Borrebaeck; Malin Lindstedt
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.